These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33317238)

  • 1. Metabolic disease as a risk of hepatocellular carcinoma.
    Nishida N
    Clin Mol Hepatol; 2021 Jan; 27(1):87-90. PubMed ID: 33317238
    [No Abstract]   [Full Text] [Related]  

  • 2. [The Development of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease].
    Kwon OS; Kim JH; Kim JH
    Korean J Gastroenterol; 2017 Jun; 69(6):348-352. PubMed ID: 28637103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
    Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
    Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 5.  Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries.
    Seyda Seydel G; Kucukoglu O; Altinbasv A; Demir OO; Yilmaz S; Akkiz H; Otan E; Sowa JP; Canbay A
    Ann Hepatol; 2016; 15(5):662-72. PubMed ID: 27493104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma: predisposing conditions and precursor lesions.
    Bailey MA; Brunt EM
    Gastroenterol Clin North Am; 2002 Jun; 31(2):641-62. PubMed ID: 12134622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular Carcinoma, Diabetes, and Metabolic Syndrome: Correlation Does Not Mean Causality.
    Braillon A
    Am J Med; 2017 Sep; 130(9):e411. PubMed ID: 28487106
    [No Abstract]   [Full Text] [Related]  

  • 8. [Guidelines of the German Society of Digestive and Metabolic Diseases for diagnosis and therapy of hepatocellular carcinoma. German Society of Digestive and Metabolic Diseases].
    Caselmann WH; Blum HE; Fleig WE; Huppert PE; Ramadori G; Schirmacher P; Sauerbruch T
    Z Gastroenterol; 1999 May; 37(5):353-65. PubMed ID: 10413843
    [No Abstract]   [Full Text] [Related]  

  • 9. A young patient with type 2 diabetes associated non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma.
    Michel M; Kalliga E; Labenz C; Straub BK; Wörns MA; Galle PR; Schattenberg JM
    Z Gastroenterol; 2020 Jan; 58(1):57-62. PubMed ID: 31931541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of metabolic syndrome in gastroenterology].
    Dítě P; Přinosilová J; Dovrtělová L; Kupka T; Nechutová H; Kianička B; Břegová B; Kunovský L; Martínek A; Souček M
    Vnitr Lek; 2015 Sep; 61(9):792-8. PubMed ID: 26465278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Massoud O; Charlton M
    Clin Liver Dis; 2018 Feb; 22(1):201-211. PubMed ID: 29128057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epidemiology of Hepatocellular Carcinoma in the USA.
    Kim HS; El-Serag HB
    Curr Gastroenterol Rep; 2019 Apr; 21(4):17. PubMed ID: 30976932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis.
    Wainwright P; Scorletti E; Byrne CD
    Curr Diab Rep; 2017 Apr; 17(4):20. PubMed ID: 28290049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we.
    Tsoulfas G
    World J Gastroenterol; 2019 Aug; 25(29):3842-3848. PubMed ID: 31413522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Imaging diagnosis of hepatocellular carcinoma].
    Lee WJ
    Korean J Gastroenterol; 2005 Apr; 45(4):234-46. PubMed ID: 15843749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MR image of early hepatocellular carcinoma and hepatocellular carcinoma with early components].
    Muramatsu Y; Nawano S; Moriyama N; Takayasu K
    Nihon Rinsho; 1991 Aug; 49(8):1815-20. PubMed ID: 1664886
    [No Abstract]   [Full Text] [Related]  

  • 17. Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk?
    Lange N; Dufour JF
    Dig Dis Sci; 2019 Apr; 64(4):903-909. PubMed ID: 30863952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of connective tissue growth factor in the livers of non-viral hepatocellular carcinoma patients with metabolic risk factors.
    Akahoshi K; Tanaka S; Mogushi K; Shimada S; Matsumura S; Akiyama Y; Aihara A; Mitsunori Y; Ban D; Ochiai T; Kudo A; Arii S; Tanabe M
    J Gastroenterol; 2016 Sep; 51(9):910-22. PubMed ID: 26739296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity as a cause of hepatocellular carcinoma.
    Kew MC
    Ann Hepatol; 2015; 14(3):299-303. PubMed ID: 25864208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease.
    Degasperi E; Colombo M
    Lancet Gastroenterol Hepatol; 2016 Oct; 1(2):156-164. PubMed ID: 28404072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.